The utility of annual growth velocity standard deviation scores and measurements of biochemical parameters in long-term treatment monitoring of children with 21-hydroxylase deficiency.


Dilek S. O., TURAN İ., GÜRBÜZ F., Celiloglu C., YÜKSEL B.

Hormones (Athens, Greece), cilt.21, sa.3, ss.391-397, 2022 (SCI-Expanded) identifier identifier identifier

  • Yayın Türü: Makale / Tam Makale
  • Cilt numarası: 21 Sayı: 3
  • Basım Tarihi: 2022
  • Doi Numarası: 10.1007/s42000-022-00354-1
  • Dergi Adı: Hormones (Athens, Greece)
  • Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus, EMBASE, MEDLINE
  • Sayfa Sayıları: ss.391-397
  • Anahtar Kelimeler: 21-hydroxylase deficiency, 17-hydroxyprogesterone, Annual growth velocity, Final height, CONGENITAL ADRENAL-HYPERPLASIA, MASS-SPECTROMETRY, HEIGHT, PHARMACOKINETICS, HYDROCORTISONE, THERAPY, PUBERTY, PLASMA, INDEX, LIFE
  • Çukurova Üniversitesi Adresli: Evet

Özet

Purpose This study aimed to investigate the utility of annual growth velocity (GV) standard deviation scores (SDSs) and compatibility and effectiveness of biochemical parameters in long-term treatment monitoring and management of 21-hydroxylase deficiency (21-OHD) in children.